[{"AccountsPayableCurrent_0_Q1_USD":5158000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":2000.0,"FinanceLeaseInterestExpense_1_Q1_USD":3000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":0.0,"ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_0_Q1_USD":1976000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":4085000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1160000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3038000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1715000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1160000.0,"OtherLiabilitiesCurrent_0_Q1_USD":551000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":15000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":26449000.0,"AccountsAndOtherReceivablesNetCurrent_0_Q1_USD":14390000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":38000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":5700000.0,"SellingAndMarketingExpense_1_Q1_USD":8125000.0,"OperatingLeaseExpense_1_Q1_USD":213000.0,"DeferredRevenueCurrent_0_Q1_USD":30000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-13174000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":493969000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":851000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-19000.0,"FinanceLeaseLiability_0_Q1_USD":87000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":49000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":97000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":55000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":7489000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":150000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":19000.0,"PaidInKindInterest_1_Q1_USD":323000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.125,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2967000.0,"OperatingLeasePayments_1_Q1_USD":215000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2764000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":502000.0,"OperatingLeaseLiability_0_Q1_USD":3266000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1115000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":19990000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":652000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":849000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":815000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4381000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-1944000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_1_Q1_USD":2320000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.125,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":14000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":86000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":7000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":10000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":42000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":889000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":187000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1730000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":54000.0,"ProfitLoss_1_Q1_USD":-13174000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":20285000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5647000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":16000.0,"NetIncomeLoss_1_Q1_USD":-13174000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16345000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-16000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":20446000.0,"LiabilitiesCurrent_0_Q1_USD":10298000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":80290000.0,"Liabilities_0_Q1_USD":63816000.0,"InventoryNet_0_Q1_USD":3358000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4360000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.11,"Depreciation_1_Q1_USD":33000.0,"CommonStockValue_0_Q1_USD":125000.0,"CommonStockSharesOutstanding_0_Q1_shares":124741832.0,"CommonStockSharesIssued_0_Q1_shares":124741832.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":26299000.0,"AssetsCurrent_0_Q1_USD":49694000.0,"Assets_0_Q1_USD":80290000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":16777801.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":840000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":425000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-478460000.0,"StockholdersEquity_0_Q1_USD":16474000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":115530000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":27054000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":68322000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":486812.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":1.23,"AccruedProfessionalFeesCurrent_0_Q1_USD":429000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":1221000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":615000.0,"ShareBasedCompensation_1_Q1_USD":1160000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":4853000.0,"PreferredStockValue_0_Q1_USD":0.0,"LongTermDebtNoncurrent_0_Q1_USD":47716000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-11444000.0,"OperatingExpenses_1_Q1_USD":18933000.0,"InterestPaidNet_1_Q1_USD":1290000.0,"InterestExpense_1_Q1_USD":1784000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":41268000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":4559000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"VariableLeaseCost_1_Q1_USD":9000.0,"Ticker":"EYPT","CIK":"1314102","name":"EYEPOINT PHARMACEUTICALS, INC.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]